Anatoli Malyguine

Statistics

Publications

Citations

1.2K

H-Index

Active since

1996

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

Frederick National Laboratory for Cancer Research

Center for Cancer Research

Duke Medical Center

Anatoli Malyguine is an author at Science Applications International Corporation (United States) specializing in immunology, life sciences, and oncology.

Publications per year

1996–2016

Publications

IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells

Rosalba Salcedo, Jimmy K. Stauffer, Erin Lincoln et al. · The Journal of Immunology · 2004 · 160 citations · Full text

Medicine, Immunology, Oncology +17

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

Kimberly Shafer-Weaver, Thomas J. Sayers, Susan Strobl et al. · Journal of Translational Medicine · 2003 · 115 citations · Full text

Life Sciences, Immunology, Oncology +16

Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses

William J. Murphy, Timothy Back, Julie A. Hixon et al. · The Journal of Immunology · 2003 · 98 citations · Full text

Life Sciences, Immunology, Oncology +17

Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells

Kimberly Shafer-Weaver, Michael J. Anderson, Katherine E. Stagliano et al. · The Journal of Immunology · 2009 · 79 citations · Full text

Medicine, Immunology, Oncology +17

HUMAN NATURAL KILLER CELLS INDUCE MORPHOLOGIC CHANGES IN PORCINE ENDOTHELIAL CELL MONOLAYERS1

Anatoli Malyguine, Soheyla Saadi, Jeffrey L. Platt et al. · Transplantation · 1996 · 71 citations

Life Sciences, Cell Biology, Immunology +10

1–5 of 23